Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome
Authors:
- S WeerakietSWS Weerakiet
- C SrisombutCSC Srisombut
- P BunnagPBP Bunnag
- S SangtongSSS Sangtong
- N ChuangsoongnoenNCN Chuangsoongnoen
- A RojanasakulARA Rojanasakul
- 22 October 2001
- journal article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 75 (2) , 177-184
Abstract
To determine the prevalence of abnormalities of glucose metabolism in Asian women with polycystic ovary syndrome (PCOS) and to assess the different impacts of the 1985 and 1999 WHO consultations and the ADA criteria for the diagnosis of type 2 diabetes mellitus (DM). Eighty-five women with PCOS were consecutively included in the study at the Reproductive Endocrinology Unit, Department of Ob-Gyn, Ramathibodi Hospital, Mahidol University. All women underwent a standard oral glucose tolerance test (OGTT). Fasting insulin and testosterone levels were also measured. Seventy-nine women consented to the OGTT. The prevalence of impaired glucose tolerance (IGT) and type 2 DM was 22.8 and 15.2% with the 1985 WHO criteria, and 20.3 and 17.7% according to the 1999 WHO consultation criteria, respectively. The recommendation of the ADA using the fasting glucose levels could only determine a prevalence of 6.3% for type 2 DM. The fasting insulin and testosterone levels were significantly higher in DM than IGT and normal glucose tolerance (NGT) subgroups. The PCOS women with abnormalities of glucose metabolism had a greater body mass index (BMI), higher fasting glucose and 2-h post-load glucose levels than those with NGT. The prevalence of glucose intolerance significantly increased with BMI. Similar to other ethnic populations, Asian women with PCOS are at risk of developing IGT and type 2 DM especially if obese. The recommendation of the ADA is not appropriate for the diagnosis of type 2 DM in PCOS women.Keywords
This publication has 17 references indexed in Scilit:
- Screening for type 2 diabetes.Diabetes Care, 2000
- Dyslipidaemia in poly cystic ovarian syndrome: different groups, different aetiologies?Human Reproduction, 1996
- Polycystic ovary syndrome--from gynaecological curiosity to multisystem endocrinopathyHuman Reproduction, 1996
- Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1995
- Steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia)The American Journal of Medicine, 1995
- Insulin Resistance and Insulin Secretory Dysfunction as Precursors of Non-Insulin-Dependent Diabetes Mellitus: Prospective Studies of Pima IndiansNew England Journal of Medicine, 1993
- Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.BMJ, 1986
- Insulin Resistance in Nonobese Patients with Polycystic Ovarian Disease*The Journal of Clinical Endocrinology & Metabolism, 1983
- CUSHING'S SYNDROME?KILLING DISEASE: DISCRIMINATORY VALUE OF SIGNS AND SYMPTOMS AIDING EARLY DIAGNOSISThe Lancet, 1982
- Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose IntoleranceDiabetes, 1979